118 related articles for article (PubMed ID: 27554866)
41. Proton translocating ATPase mediated fungicidal activity of eugenol and thymol.
Ahmad A; Khan A; Yousuf S; Khan LA; Manzoor N
Fitoterapia; 2010 Dec; 81(8):1157-62. PubMed ID: 20659536
[TBL] [Abstract][Full Text] [Related]
42. Geraniol interferes with membrane functions in strains of Candida and Saccharomyces.
Bard M; Albrecht MR; Gupta N; Guynn CJ; Stillwell W
Lipids; 1988 Jun; 23(6):534-8. PubMed ID: 3050345
[TBL] [Abstract][Full Text] [Related]
43. Chemical composition and antifungal activity of the essential oil of Origanum virens on Candida species.
Salgueiro LR; Cavaleiro C; Pinto E; Pina-Vaz C; Rodrigues AG; Palmeira A; Tavares C; Costa-de-Oliveira S; Gonçalves MJ; Martinez-de-Oliveira J
Planta Med; 2003 Sep; 69(9):871-4. PubMed ID: 14598221
[TBL] [Abstract][Full Text] [Related]
44. Interesting anticandidal effects of anisic aldehydes on growth and proton-pumping-ATPase-targeted activity.
Shreaz S; Bhatia R; Khan N; Ahmad SI; Muralidhar S; Basir SF; Manzoor N; Khan LA
Microb Pathog; 2011 Oct; 51(4):277-84. PubMed ID: 21669279
[TBL] [Abstract][Full Text] [Related]
45. The relationship between antifungal usage and antifungal susceptibility in clinical isolates of Candida: a multicenter Korean study.
Kim SH; Shin JH; Kim EC; Lee K; Kim MN; Lee WG; Uh Y; Lee HS; Lee MK; Jeong SH; Jung SI; Park KH; Lee JS; Shin MG; Suh SP; Ryang DW
Med Mycol; 2009 May; 47(3):296-304. PubMed ID: 18668423
[TBL] [Abstract][Full Text] [Related]
46. Correlation of posaconazole minimum fungicidal concentration and time kill test against nine Candida species.
Sóczó G; Kardos G; McNicholas PM; Balogh E; Gergely L; Varga I; Kelentey B; Majoros L
J Antimicrob Chemother; 2007 Nov; 60(5):1004-9. PubMed ID: 17875607
[TBL] [Abstract][Full Text] [Related]
47. Rapid identification of fluconazole resistance using Chromagar Candida.
Verghese SL; Padmaja P; Sutha P; Mathew T; John ES
Indian J Pathol Microbiol; 2000 Jul; 43(3):343-6. PubMed ID: 11218683
[TBL] [Abstract][Full Text] [Related]
48. Antimycotic effect of the essential oil of Aloysia triphylla against Candida species obtained from human pathologies.
Oliva Mde L; Carezzano ME; Gallucci MN; Demo MS
Nat Prod Commun; 2011 Jul; 6(7):1039-43. PubMed ID: 21834253
[TBL] [Abstract][Full Text] [Related]
49. Antifungal potential of eugenyl acetate against clinical isolates of Candida species.
Musthafa KS; Hmoteh J; Thamjarungwong B; Voravuthikunchai SP
Microb Pathog; 2016 Oct; 99():19-29. PubMed ID: 27452957
[TBL] [Abstract][Full Text] [Related]
50. 2-hydroxyisocaproic acid is fungicidal for Candida and Aspergillus species.
Sakko M; Moore C; Novak-Frazer L; Rautemaa V; Sorsa T; Hietala P; Järvinen A; Bowyer P; Tjäderhane L; Rautemaa R
Mycoses; 2014 Apr; 57(4):214-21. PubMed ID: 24125484
[TBL] [Abstract][Full Text] [Related]
51. In vitro susceptibility of Candida species isolated from blood culture to some antifungal agents.
Citak S; Ozçelik B; Cesur S; Abbasoğlu U
Jpn J Infect Dis; 2005 Feb; 58(1):44-6. PubMed ID: 15728993
[TBL] [Abstract][Full Text] [Related]
52. The antifungal properties of chicken egg cystatin against Candida yeast isolates showing different levels of azole resistance.
Kolaczkowska A; Kolaczkowski M; Sokolowska A; Miecznikowska H; Kubiak A; Rolka K; Polanowski A
Mycoses; 2010 Jul; 53(4):314-20. PubMed ID: 19549107
[TBL] [Abstract][Full Text] [Related]
53. Comparison of posaconazole and voriconazole in vitro killing against Candida krusei.
Cantón E; Pemán J; Valentín A; Bosch M; Espinel-Ingroff A; Gobernado M
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):177-81. PubMed ID: 18691842
[TBL] [Abstract][Full Text] [Related]
54. A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.
Diekema DJ; Messer SA; Hollis RJ; Boyken L; Tendolkar S; Kroeger J; Jones RN; Pfaller MA
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):233-6. PubMed ID: 19070452
[TBL] [Abstract][Full Text] [Related]
55. Study of strains of Candida spp. Isolated from catheters in UHC of Oran (Algeria): Identification and antifungal susceptibility.
Bendjelloul M; Boucherit-Otmani Z; Boucherit K
J Mycol Med; 2016 Sep; 26(3):212-6. PubMed ID: 27103075
[TBL] [Abstract][Full Text] [Related]
56. In vitro inhibitory activity of terpenic derivatives against clinical and environmental strains of the Sporothrix schenkii complex.
Brilhante RS; Silva NF; Marques FJ; Castelo-Branco Dde S; de Lima RA; Malaquias AD; Caetano EP; Barbosa GR; de Camargo ZP; Rodrigues AM; Monteiro AJ; Bandeira Tde J; Cordeiro Rde A; Sidrim JJ; Moreira JL; Rocha MF
Med Mycol; 2015 Feb; 53(2):93-8. PubMed ID: 25541558
[TBL] [Abstract][Full Text] [Related]
57. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Dagi HT; Findik D; Senkeles C; Arslan U
Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
[TBL] [Abstract][Full Text] [Related]
58. Anti-Candida albicans effectiveness of citral and investigation of mode of action.
Lima IO; de Medeiros Nóbrega F; de Oliveira WA; de Oliveira Lima E; Albuquerque Menezes E; Cunha FA; Formiga Melo Diniz Mde F
Pharm Biol; 2012 Dec; 50(12):1536-41. PubMed ID: 23116193
[TBL] [Abstract][Full Text] [Related]
59. The possible mechanism of rhapontigenin influencing antifungal activity on Candida albicans.
Kim N; Kim JK; Hwang D; Lim YH
Med Mycol; 2013 Jan; 51(1):45-52. PubMed ID: 22662760
[TBL] [Abstract][Full Text] [Related]
60. Prevalence and Fluconazole Susceptibility Profile of Candida spp. Clinical Isolates in a Brazilian Tertiary Hospital in Minas Gerais, Brazil.
Neves-Junior A; Cartágenes-Pinto AC; Rocha DA; de Sá LF; Junqueira Mde L; Ferreira-Pereira A
An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1349-59. PubMed ID: 26312420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
